Magnetic particle imaging system for cancer diagnosis: an overview by Sadiq, A. A. et al.
 
 
 
 
VOL. X, NO. X, XXXXXXXX 
ARPN Journal of Engineering and Applied Sciences 
 
©2006-2013 Asian Research Publishing Network (ARPN). All rights reserved. 
ISSN 1819-6608 
 
 
 
  
 
www.arpnjournals.com 
 
MAGNETIC PARTICLE IMAGING SYSTEM FOR CANCER DIAGNOSIS: AN 
OVERVIEW 
 
A. A. Sadiq, N. B. Othman* and M. M. Abdul Jamil 
Biomedical Modelling and Simulation Research Group, Faculty of Electrical and Electronics Engineering, 
Universiti Tun Hussein Onn Malaysia, Batu Pahat, Johor, Malaysia. 
*Corresponding author: engrsadiqgam@gmail.com 
 
ABSTRACT 
Medical diagnosis over the last decades have been reformed by tomographic imaging and has become a vital tool for 
diagnosis of several diseases. Magnetic particle imaging (MPI) as a new quantitative imaging method, uses the nonlinear re-
magnetization behavior of magnetic nanoparticles to determine their local concentration. This paper presents an overview of a 
proposed method to design and construct an MPI scanner that will diagnose cancer. It is expected at the end of the research to 
come up with an extremely sensitive scanner that will detect the position of magnetic nanoparticles (MNPs) used as tracers in 
diagnosing cancer by producing a high temporal and spatial resolution images. 
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INTRODUCTION 
Magnetic particle imaging (MPI) is a novel imaging modality 
that accomplishes a direct measurement of the magnetization 
of ferromagnetic nanoparticles to calculate their local 
concentration. Superparamagnetic Iron oxide nanoparticles 
(SPIONS) are usually employed as tracer material in MPI, 
due to their small size and exhibit Superparamagnetism. 
These SPIONs are injected into a target area, then excited by 
an external magnetic field (Drive field) and the response of 
the particles is recorded which is proportional to the 
concentration of the SPIONs. 
MPI technique was invented in 2001 by Bernhard 
Gleich and Jürgen Weizenecker, who first reported on it in 
nature in 2005 [1]. MPI offers a unique combination of 
capabilities that sets it apart from other established 
modalities for medical imaging. An essential theory for 
describing the magnetic behavior of superparamagnetic 
particles is the Langevin theory, which is defined under the 
assumption that the particles are always in thermal 
equilibrium. Gleich et al. (2012) reported that MPI usually 
aims at applications requiring fast, dynamic imaging, such as 
blood flow visualization in the case of coronary artery 
diseases. Furthermore, future applications may be in cancer 
diagnosis, sentinel lymph node biopsy or any application 
where tracers are used for diagnosis today (MRI, PET, and 
SPECT). 
The aim of this research is to design and construct a 
magnetic particle imaging system (scanner) for cancer 
diagnosis. This will be achieved by exposing the sample 
containing the MNPs and the cancer cells in a magnetic field 
produced by the drive coil. The magnetization of the MNPs 
will induce a voltage signal in the pickup coil that is being 
detected in the form of harmonics. These harmonics will be 
amplified and acquired using appropriate data acquisition 
hardware and software to produce tomographic images of the 
tracer material used. 
 
METHODOLOGY 
The spatial distribution of MNPs used as tracer material can 
be determined by measuring the change in the magnetization 
of the tracer material in a time-varying magnetic field. Figure 
1 shows the relationship between the external magnetic field 
applied to the MNPs and their response magnetization. This 
is as demonstrated by the M-Hcurve in the upper left part of 
figure 1. The dynamic region of the magnetization curve is 
non-linear when a field of A to –A is applied, while the 
saturation area started when the field-applied is beyond A. 
No further magnetization is made and this results in the 
occurrence of harmonics in the received signal. These 
harmonics are used to reconstruct the images that reveal the 
presence of magnetic material. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: External magnetic field applied to the MNPs and 
their response magnetization 
 
MPI takes advantage of the non-linear magnetization 
behavior of SPIOs used as tracer material, to detect their 
spatial and temporal distribution within a target cancerous 
tissue (Othman et al., 2014). Equation (1) gives the 
magnetization behavior of these particles, which be 
approximated by the Langevin function. 
MD(t) = msc (coth(ξ))-1/ ξ) . (1) 
The magnetization of a distribution of particles of diameter 
D is described by  MD while ms=(πD3Ms)/6 denotes the 
magnetic moment at saturation. The saturation magnetization 
Ms is a material constant. The particle concentration is given 
by c, and the Langevin parameter is given as: 
ξ = (msµ0H(t))/(KBTP).   (2) 
 H(t) = √2Hacsin(wt) + Hdc .  (3) 
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In which H(t) is the outer magnetic field, kB is the Boltzmann 
constant, TP is the temperature of the magnetic material, and 
µ0 is the permeability of vacuum (Buzug et al., 2012). Using 
a sinusoidal external magnetic field, entitled drive field Hdc, 
with frequency f0, a non-sinusoidal oscillation of the particle 
magnetization M is brought due to the non-linearity of the 
Langevin function. In Fourier space, this deformation can be 
detected as higher harmonic frequency components (Othman 
et al., 2014). 
 
MAGNETIC NANOPARTICLES: STRUCTURE AND 
SYNTHESIS 
Magnetic nanoparticles (MNPs) are a class of nanoparticle 
which can be manipulated using a magnetic field. 
Nanoparticles possessing magnetic properties offer 
significant advantages in that they can provide selective 
attachment to a functional molecule, confer magnetic 
properties to a target, and allow manipulation and 
transportation to a desired location under the control of a 
magnetic field produced by an electromagnet or permanent 
magnet (Wadajkar, Menon, Kadapure, Tran, & Yang, 2013). 
MNPs are agents that are superparamagnetic and consist of a 
central core of iron-oxide, surrounded by a carbohydrate or 
polymer coat. The size, physical properties and 
pharmacokinetics of MNPs make them highly suited for 
cellular and molecular imaging of atherosclerotic plaque and 
myocardial injury (Sosnovik et al., 2008). 
The physical and chemical properties of magnetic 
nanoparticles largely depend on the synthesis method and 
chemical structure. In most cases, the particles range from 1 
to 100 nm in size and may display superparamagnetism 
(Morishige et al., 2014). This superparamagnetic possession 
of materials is useful in that individual particles become 
magnetized only when exposed to an external magnetic field, 
but exhibit no remnant magnetization when the field is 
removed (Issa, Obaidat, Albiss, & Haik, 2013). Magnetic 
nanoparticle carriers consist of three functional parts: a 
magnetic core, a surface coating, and a functionalized outer 
coating (Pantic, 2010).  Magnetic iron oxide particles 
(ferromagnetic magnetite-Fe3O4 and maghemite-Fe2O3),  on 
the other hand, are highly biocompatible, because the iron 
uptake, excretion, and storage are well controlled, and the 
iron excess is efficiently cleared from the body without grave 
consequences to human health (Miller, 2013). Most synthesis 
procedures for medically applicable nanomaterials are 
inexpensive and based on simple chemical reactions. 
Meanwhile, nanoparticles at the target site, even with their 
small size, do not enter into biological systems easily, many 
investigators suggest that it is indispensable to design 
approaches that enable nanoparticles to identify the surface 
molecules/receptors of the target cells and, therefore 
permitting nanoparticles to enter the cells and their 
organelles (Yan et al., 2006). 
Various types of nanoparticles have been developed for 
application in cancer diagnosis/therapy: inorganic (iron 
based (magnetic) and other inorganic nanoparticles) and 
organic nanoparticles (Ishihara et al., 2013). Organic 
Nanoparticles are those prepared with organic polymers, 
with examples such as liposomes, dendrimers, and carbon 
nanotubes. According to Akhter et al. (2011), Inorganic, on 
the other hand, is those prepared with inorganic elements. 
Examples are magnetic nanoparticles (iron oxide 
nanoparticles), gold nanoparticles, and quantum dots. Today, 
there are several commercially available contrast agents for 
MRI. These include Resovist (Schering), FluidMAG-D and 
Nanomag-D. 
 
APPLICATIONS OF MAGNETIC NANOPARTICLES 
IN BIOMEDICAL FIELD 
Magnetic Nanoparticles may provide advanced biomedical 
research tools based on polymeric or inorganic formulations 
or a combination of both. They have the potential to be used 
in many different biological and medical applications as in 
diagnostic tests assays for early detection of diseases, to serve 
as tools for non-invasive imaging and drug development, and 
to be used as targeted drug delivery systems to minimize 
secondary systemic adverse effect. These applications fall 
broadly into two categories: those involving the use in-vivo 
and those involving the use of magnetic particles in-vitro. 
 
i. Imaging: 
For many years, superparamagnetic nanoparticles 
have been used in diagnostics as contrast agents in 
magnetic resonance imaging (MRI), magnetic 
resonance angiography (MRA) and magnetic 
particle imaging (MPI). MNPs are considered as 
promising contrast agents in cancer diagnosis 
because they have much greater magnetic 
susceptibility than traditional magnetic contrasts, 
such as gadolinium. Other advantages of using 
MNPs in cancer diagnosis include; they are 
nontoxic, biocompatible and affordable. 
Magnetic particle imaging (MPI) is proposed as a 
new imaging tool to overcome the limitations of CT, 
MRI, and SPECT by employing the magnetization 
response of SPIO nanoparticles to generate a 
tomographic image. The image is characterized 
qualitatively by high spatial resolution that is 
comparable to that of CT image, and high sensitivity 
as good as PET image. 
 
ii. Drug delivery 
In magnetically targeted therapy, a cytotoxic drug is 
attached to a biocompatible MNP carrier. These 
drug/carrier complexes-usually in the form of a 
biocompatible ferrofluid, are injected into the 
patient via the circulatory system. When the MNPs 
have entered the blood vessel, high-gradient 
magnetic fields are externally applied to concentrate 
the drug or carrier compound at a particular target 
site within the body. Gene delivery has been done 
using viral or non-viral carriers for the past two 
decades. However, their use has some limitations 
and severe side effects. MNPs are non-viral tools, 
complemented with DNA, plasmids or interfering 
RNA for gene transfer.  
Chomoucka et al. (2010) reviewed the parameters 
influencing drug delivery efficiency and 
functionalization of MNPs for targeted drug 
delivery. Constraints such as the physiochemical 
properties of the drug-loaded MNPs, field strengths 
and geometry, depth of the target tissue, rate of 
blood flow and vascular supply, all play a role in 
determining the effectiveness of the drug delivery. 
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iii. Immunoassay:  
An immunoassay is a biochemical investigation 
used in a wide field of biotechnology measurement, 
e.g. for the detection of pathogens and cancer cells, 
DNA gene analysis, detection of environmental 
toxins, and immune response. The immune 
response is obtained by measuring the binding 
reaction between a particular bio-substance to be 
measured, referred as antigen, and the diagnostic 
reagent that selectively bind to that antigen, applied 
as an antibody. Immunoassay relies on the ability of 
the antibody to recognize and bind a specific antigen 
to measure the type and amount of the antigen in 
vitro. 
Magnetic immunoassay is a novel type of diagnostic 
immunoassay using the magnetic marker as label 
instead of other conventional labels. This assay 
involves the particular binding of an antibody to its 
antigen, where a magnetic label is conjugated to one 
element of the pair. The presence of magnetic beads 
is then detected by a magnetic reader that measures 
the magnetic field change induced by the beads. The 
signal measured by the magnetometer is 
proportional to the analyte quantity in the initial 
sample. 
 
iv. Hyperthermia 
MNPs have been used significantly in cancer 
therapy, particularly in magnetic target 
hyperthermia. Hyperthermia is a type of medical 
treatment of localized heating the body tissue to 42-
46°C using MNPs to kill or damage tumor cells. 
This is achieved by injecting nanoparticles into a 
target site and the exposed to a magnetic field. The 
nanoparticles convert the electromagnetic energy 
into heat, thereby heating the target tissues without 
affecting other nearby tissues. Huang and Hainfeld 
(2013) carried out research on intravenous magnetic 
nanoparticles cancer hyperthermia. MNP was 
injected intravenously to the target tumor areas to 
achieve tumor concentration of 1.9mgFe/g tumor in 
a sub-cutaneous squamous cell carcinoma mouse 
model. With the applied field of 38 kA/m at 980 
kHz, the tumor cells were heated at 60ºc in 2 minutes 
and were ablated with millimeter precision, without 
affecting surrounding tissues. 
There are many types of MNPs products that have been 
developed for biomedical applications: Resovist® (Fujifilm 
RI Pharma), EndoremTM(Guerbet S. A.), 
Feraheme®(AMAG Pharmaceuticals), 
Nanotherm®(MagForce Nanotechnologies) etc. Instead of 
some are already commercially available on the market for 
clinical use. However, majorities of them are remaining at 
the development level. 
The ongoing research is directed towards 
monitoring events on the physiological and molecular level 
so that inflammatory diseases or tumors can be detected via 
the accumulation of SPIONs or markers expressed on the cell 
surface. 
 
 
 
CURRENT STATUS OF MPI SYSTEM 
 
FIELD FREE POINT (FFP) 
Field Free Point (FFP) is a precise position created when a 
gradient magnetic field is applied to MNP sample and 
superimposed on the selection field, generated by the 
selection or balancing coil. At FFP, the majority of the 
particles in space are saturated such that only particles in the 
close vicinity of the FFP respond when the applied magnetic 
field changes. To speed up the imaging process, one just has 
to break the rule that the FFP has to stay within an image 
voxel during one measurement. Instead, by increasing the 
excitation field amplitude, the FFP is moved back and forth 
along a line in the direction of the field vector of the 
excitation field. 
 
FIELD FREE LINE (FFL) 
Field Free Line (FFL) is similarly created like the FFP, by 
superimposing the field from the drive coil on the magnetic 
field generated by the selection field coils, which are not 
static but rotates with a particular frequency fs. This 
frequency fs is much lower than the excitation frequency of 
the drive coil. Therefore, FFL trajectory is produced by the 
dynamic rotation of the magnetic field from the selection 
field. 
Besides FFP imaging, Weizenecker et al. (2008), introduced 
a coil arrangement to generate an FFL that promises a higher 
sensitivity due to particle contribution along a line. Initially, 
the setup consisted of 32 coils and was unfeasible to realize. 
In 2010, Knopp et al. picked up the idea, developed 
techniques to generate an FFL with just eight coils and 
presented an efficient FFL reconstruction based on the 
Fourier Slice Theorem. Continuously, new MPI approaches 
are being shown that are related to frequency space and x-
space MPI, such as narrowband MPI and traveling wave MPI 
(Cole, Yang, & David, 2011). 
The first difference between FFP and FFL is the shape of the 
field-free region, i.e., the area in which SPION tracer particle 
contribute to the acquired signal. For FFP is a circular point 
while for FFL is a straight line. The second difference is that 
the selection field for FFP is a static while for FFL requires a 
rotation of at least 180 degrees.    
  
IMAGE RECONSTRUCTION 
According to the literature, there are three techniques for MPI 
signal reconstruction. The most published procedure is 
harmonic-space MPI, which uses a system matrix that is 
comprised of the Fourier components of the temporal signal 
for every possible location of a point source. Reconstruction 
is achieved through regularization and matrix inversion 
techniques such as singular value decomposition or algebraic 
reconstruction. This inversion can be complicated since the 
size of the system matrix is large and contains millions of 
elements. The second technique is a narrowband technique, 
which reconstructs harmonic images into a composite image 
using a modified Wiener deconvolution. The third method is 
x-space reconstruction. X-space offers several advantages 
over harmonic-space MPI matrix 
reconstructions. Specifically, x-space MPI is experimentally 
proven to generate Linear Shift-Invariant (LSI) images, as 
well as real-time image reconstruction speed as it involves 
only division by a scalar to reconstruct each point in the 
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picture. Importantly, x-space MPI makes no attempt to 
deconvolve the MPI signal to improve resolution at the 
resolution determined by the physics of the nanoparticles and 
field gradient, and thus avoids the significant noise gain of 
deconvolution. 
Buzug et al. (2012) described the frequency-based 
image reconstruction approach and the corresponding 
imaging devices as well as other alternative concepts like x-
space MPI and field-free line imaging (FFL). Additionally, 
Goodwill et al. introduced a reconstruction principle in the 
time domain, called x-space MPI. Within the hypothesis of 
consistent magnetic fields, i.e. assuming a linear shift-
invariant system, and conventional in the Langevin theory of 
paramagnetism a correlation between FFP position and 
induced voltage signal can be created and direct 
reconstruction becomes possible. The most significant 
advantage of x-space MPI is the omitted system matrix such 
that a scanner dependent calibration process is no longer 
necessary. Although deconvolution is not essential, it most 
likely improves image quality. 
  
PROPOSED MPI SCANNER  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Proposed MPI Scanner 
 
The block diagram of the proposed scanner is as shown in 
Figure 2. The drive field signal is generated by a signal 
generator. The signal then passes a power amplifier for 
appropriate field generation. Because even high linear 
amplifiers generate harmonic distortions, a band pass filter is 
used to keep the signal on the coils clean. For this purpose, a 
third order Butterworth or Chebycheff II filter may be 
applied (Tanaka, Murata, Oishi, Suzuki, & Zhang, 2014). To 
obtain a purely sinusoidal signal the filter needs to be of high 
quality. The magnetic field generated can be described as: 
H = hI.     (4) 
Where h is the sensitivity profile of the magnetic 
field well-defined by the coil geometry, and I is the current. 
To achieve a high magnetic field strength, another magnetic 
field is produced by the balancing coils and superimposed on 
the generated drive field. This will create a field free point, 
where only the drive field will have an effect on the MNPs. 
Since the drive field signal combines into the balancing field 
coils, band stop filters are required to protect the DC source 
against the induced AC voltage. The particle magnetization 
changes depending on the actual resulting magnetic field, 
which produces a voltage signal in a receiver coil. 
Additionally, the received signal passes through another band 
stop filter to damp the fundamental frequency, which couples 
directly into the pick-up coil. Then the signal has to be 
amplified to match the dynamic range of the data acquisition 
hardware to achieve the highest possible resolution. The 
image of the MNPs tracer is then reconstructed with the 
harmonics signals obtained from the low noise amplifier.   
CONCLUSION 
MPI is a promising new modality that has a lot of potential 
for diagnostics as well as therapy. It can be utilized to 
perform a quantitative detection of magnetic tracer materials 
based on superparamagnetic iron oxide with high temporal 
and spatial resolution. An overview of MPI and a proposed 
scanner which will be used to diagnose cancer is presented. 
The proposed MPI scanner will be realized by designing and 
constructing each component of the block diagram shown. 
FFP technique is going to be employed in the implementation 
due to its simplicity, and a harmonic space MPI 
reconstruction method is going to be adapted. Finally, 
Resovist nanoparticle will be used as a tracer material and the 
sample will be prepared and experimented in-vitro, where the 
sample mixture containing SPIONs, cancer cells, and healthy 
cells will be inserted into a cell culture flask. 
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